Navigation Links
Symtrex Inc. Signs Up with ImmuneSecurity to Launch LogInspect to the North American Market
Date:6/21/2012

Toronto, Ontario (PRWEB) June 21, 2012

Symtrex Inc. is please to announce that they have entered into an agreement with ImmuneSecurity to launch LogInspect 5 SIEM to the North American market.

Symtrex Inc. specialists in network security, approached ImmuneSecurity after searching for a product that would satisfy their client’s requirements for compliance regulations as well as improve the security posture of their networks. LogInspect is the perfect addition to their product mix.

LogInspect 5 changes the game for Security Information & Event Management (SIEM). Robust, dynamic and unparalleled, this solution is already helping European enterprise companies fight cybercrime and internal threats, manage compliance demands, and ultimately generate business value thanks to unmatched data correlation, searches, reporting and dashboards.

“Symtrex has been in the SIEM market since 2004, and has witnessed the evolution of this market as well as the increased demands. It is not just about collecting logs, but gathering intelligence from those logs, being able to find that 'needle in the haystack.' LogInspect fits the bill.”

LogInspect, a new breed in the SIEM technology, offers a robust collection engine, analytical tools, event correlation, and more.

The benefits of LogInspect includes:

  •     Out-of-the-box compliance reports to assist meeting specific regulations such as PCI, HIPAA, NERC, SOX, GLBA and ISO 2700x
  •     An easy to use reporting engine that does not require advanced database and report writing skills, or hiring a Security expert to come in and setup the system.
  •     The ability to collect logs from any device in a network, either using agents or not.
  •     Extremely fast searching for easy forensics
  •     Powerful dashboards, individually configured

By building the product from the ground up, as well as listening to what their clients have requested Immune Security created a product that provides four Solutions in one easy to manage product – Log Management, Security Information and Event Management, Network Analysis, and File Integrity. The software is characterized by ease of deployment, ease of use, ease of management and outstanding global support.

LogInspect offers built-in scaling architecture, enabling enterprise-wide implementation that combines any hardware and virtualized appliances. Searches and reports can include any subset of any distributed LogInspect servers across the network.

About Symtrex Inc.
Symtrex is a private IT security services organization, having been in business since 1988, we provide full network and security services for clients with solutions that range from IT security compliance to network security software and compliance reporting. Contact us at 866-431-8972 or visit the website at http://www.symtrex.com.

About ImmuneSecurity
ImmuneSecurity is headquartered in Europe and are serving more than 300 customers with its solutions. Our core product is LogInspect which is a full scale Enterprise SIEM solution with global support and a strong focus on delivering superior customer support.

ImmuneSecurity have expanded their network of partners to include new mature markets in Europe, Asia and the North American market. For further information http://www.immunesecurity.com.

Read the full story at http://www.prweb.com/releases/2012/6/prweb9620056.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Even Young Teens Show Signs of Sun Damage
2. A place to play: Researcher designs schoolyard for children with autism
3. Obese Teens Can Have Heart Damage Without Showing Signs
4. TeetheMe.com Partners with SwaddleDesigns
5. IntegraGen launches ARISk test, a genetic screening tool for autism in high-risk children
6. Mayo Clinic launches whole genome breast cancer study
7. Association for Psychological Science, SAGE launch Clinical Psychological Science
8. Centre for Global Non-Communicable Diseases launched to tackle killer diseases
9. Original research papers on acute cardiovascular care: ESC launches EHJ-ACVC
10. The Ludwig Institute for Cancer Research announces launch of iTeos Therapeutics SA
11. National initiative launched to change the way biology departments approach undergraduate education
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... 28, 2017 , ... Semrock’s highly popular SearchLight Spectra Viewer ... resource for fluorescence microscopists and optical system designers, enabling The Right Solution, Right ... the globe, SearchLight has become a tremendously popular tool for the fluorescence imaging ...
(Date:4/27/2017)... ... April 27, 2017 , ... Thinksport, the leaders in safe, ... award-winning sunscreen they’ve used the same scientific approach to solving smelly, sweaty athletes, ... the aisles that contain harmful chemicals that should be put nowhere near your ...
(Date:4/27/2017)... ... April 27, 2017 , ... Offering the purest product of its ... times purer and more potent than the market has seen before. Swissx uses proprietary ... well as a patented chromatography process for extraction, to produce its CBD oil--maximizing its ...
(Date:4/26/2017)... , ... April 26, 2017 , ... Journal of ... It can have severe consequences to overall dental health, including complications with speech, eating, ... turn to dental implants to replace lost teeth. As the number of tooth replacements ...
(Date:4/26/2017)... ... April 26, 2017 , ... The ... Excellence upon National Registry of Emergency Medical Technicians and welcomes this ... said Dr. Jan G. West, Ph.D. , CEO & Organizational Psychologist at ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... DALLAS , April 19, 2017  Vanderbilt ... the first patients in Nashville , ... the Lower Esophageal Sphincter Stimulation for GERD (LESS GERD) ... designed to provide long-term reflux control by restoring normal ... affects nearly 65 million people in the ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, ... antibody-centric, clinical-stage biopharmaceutical company developing new treatments for ... the closing of its previously announced underwritten public ... at a public offering price of $2.00 per ... estimated offering expenses payable by Sorrento.  The net ...
(Date:4/19/2017)... April 19, 2017  New research provides evidence that an ... according to a study released today that will be presented ... in Boston , April 22 to ... treatment of Parkinson,s disease, the oral drug levodopa has long ... longevity. But as the disease progresses, the effects of the ...
Breaking Medicine Technology: